Tag: Vaccines
U.S. Advises Older Travelers to Avoid Chikungunya Vaccine
RSV Vaccines, Nirsevimab Tied to Reduced RSV-Linked Hospitalization
Reduction in 2024-2025 RSV-associated hospitalization rates seen among infants aged 0 to 7 months with maternal vaccination or nirsevimab
BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuberculosis Infection
Adverse events occurred more often in the BCG revaccination group, and most were due to injection-site reactions
Combined Flu, SARS-CoV-2 Vaccine as Effective as Individual Vaccines for Older Adults
mRNA-1083 induced higher immune responses than recommended standard-care influenza and COVID-19 vaccines
Nirsevimab Effective for Reducing Burden of RSV in Infants
Nirsevimab associated with lower odds of RSV-related hospitalization, ICU admission, lower respiratory tract infection incidence
Live Zoster Vaccination Linked to Lower Risk for Cardiovascular Events
In a recent study, protective association lasted for up to eight years, with greatest reduction seen at two to three years postvaccination
Dr. Vinay Prasad to Head FDA Vaccine, Biologics Division
Urticaria Reported in Trial of Investigational HIV mRNA Vaccines
7 percent of 108 healthy volunteers reported urticaria; unresolved urticaria persisted at 12 months in four participants
RFK Jr. to Change Vaccine Testing Rules
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics
The new initiative will focus on research using the beta-propiolactone vaccine platform
